SHARON HENN: Open Payments
NPI 1700307832 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,845 in 189 payments from 23 companies in 2025. Trend: 2023 $4,986 · 2024 $3,133 · 2025 $3,845
Food & beverage: $3,844Education: $1
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $532 |
| EMD Serono, Inc. | 11 | $360 |
| UCB, Inc. | 20 | $330 |
| Novartis Pharmaceuticals Corporation | 20 | $270 |
| Eisai Inc. | 8 | $244 |
| JAZZ PHARMACEUTICALS INC. | 8 | $238 |
| Lilly USA, LLC | 6 | $211 |
| PFIZER INC. | 13 | $209 |
| ARGENX US, INC. | 8 | $205 |
| ACADIA Pharmaceuticals Inc | 9 | $171 |
Products named: UBRELVY, KESIMPTA, Leqembi, EPIDIOLEX, NURTEC ODT, VYVGART, NUPLAZID, QULIPTA.
Industry payments across IN — which companies pay providers there.
